Haloperidol and Gaviscon drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Haloperidol (haloperidol) and Gaviscon (aluminum hydroxide; magnesium trisilicate). Common drug interactions include c-reactive protein increased among females and dizziness among males.

The phase IV clinical study analyzes what interactions people have when they take Haloperidol and Gaviscon. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Haloperidol?

Haloperidol has active ingredients of haloperidol. It is often used in schizophrenia. eHealthMe is studying from 16,637 Haloperidol users. Check the latest studies of Haloperidol.

What is Gaviscon?

Gaviscon has active ingredients of aluminum hydroxide; magnesium trisilicate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 12,355 Gaviscon users. Check the latest studies of Gaviscon.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 22, 2026

31 people who take Haloperidol and Gaviscon together, and have interactions are studied.

Haloperidol and Gaviscon drug interactions.

What are the common drug interactions of Haloperidol and Gaviscon, by gender? *:

female:

C-reactive protein increased
Electrocardiogram qt prolonged
Acinetobacter infection (infection by group of bacteria commonly found in soil and water)
Anaemia of chronic disease
Arthralgia (joint pain)
Arthritis bacterial (form of joint disorder that involves inflammation of one or more joints due to bacterial infection)
Blood alkaline phosphatase increased
Cerebral atrophy (decrement in size of brain)
Dyspnoea (difficult or laboured respiration)
Empyema (collection of pus in a cavity in the body)

male:

Dizziness
Headache (pain in head)
Haematemesis (vomiting of blood)
Haemoglobin decreased
Malaise (a feeling of general discomfort or uneasiness)
Tonic convulsion (the person will quickly lose consciousness and the skeletal muscles will suddenly tense, often causing the extremities to be pulled towards the body or rigidly pushed away from it)
Fall
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
Cardiomyopathy (weakening of the heart muscle)

What are the common drug interactions of Haloperidol and Gaviscon, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Abdominal pain
Back pain
Malaise (a feeling of general discomfort or uneasiness)
Pancreatitis acute (sudden inflammation of pancreas)
Vomiting

30-39:

Acinetobacter infection (infection by group of bacteria commonly found in soil and water)
Anaemia of chronic disease
Arthralgia (joint pain)
Arthritis bacterial (form of joint disorder that involves inflammation of one or more joints due to bacterial infection)
Blood alkaline phosphatase increased
C-reactive protein increased
Cerebral atrophy (decrement in size of brain)
Dyspnoea (difficult or laboured respiration)
Electrocardiogram qt prolonged
Empyema (collection of pus in a cavity in the body)

40-49:

Dizziness
Headache (pain in head)
Malaise (a feeling of general discomfort or uneasiness)
Fall
Circulatory collapse
Confusion
Convulsions (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled of muscles contract and relax rapidly and repeatedly)
Sedation

50-59:

Anaemia (lack of blood)
Antipsychotic drug level increased
Blood creatinine increased
Blood triglycerides increased
Body mass index increased
C-reactive protein increased
Constipation
Enterococcus test positive
Hepatic enzyme increased
Insomnia (sleeplessness)

60+:

Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Abnormal behaviour
Aggression
Blood potassium increased
Blood sodium decreased
Gastric cancer (stomach cancer)
Haematemesis (vomiting of blood)
Haemoglobin decreased
Renal impairment (severely reduced kidney function)

What are the existing conditions these people have? *

Affective Disorder (mental disorder): 6 people, 19.35%
Ill-Defined Disorder: 6 people, 19.35%
Abnormal Behavior: 3 people, 9.68%
Personality Disorder: 3 people, 9.68%
Nausea (feeling of having an urge to vomit): 3 people, 9.68%
Aggression: 3 people, 9.68%
Indigestion: 3 people, 9.68%
High Blood Cholesterol: 3 people, 9.68%
Diabetes: 3 people, 9.68%
Depressed Mood: 2 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Haloperidol and Gaviscon?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously